56 reports

Top ## players hold majority of stake in the market ##.

  • Insulin
  • World
  • Market Size
  • Baxter International Inc.
  • Gilead Sciences, Inc.
  • 5. INSULIN PENS MARKET - KEY MARKET DYANAMICS

TABLE ##.

  • Insulin
  • World
  • Forecast
  • Market Size
  • Novo Nordisk Group
  • 4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET - KEY MARKET DYNAMICS

TABLE ##.

  • Insulin
  • Forecast
  • DexCom, Inc.
  • Insulet Corporation
  • Medtronic, Inc.
  • PROVIDES A SWOT ANALYSIS OF FORXIGA. TABLE 63: FORXIGA SWOT ANALYSIS, 2016
  • 6.5 ITALY

STROKE; ##(##): ##-##.

  • Insulin
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.
  • DIABETES DRUGS MARKET, GLOBAL, ANNUAL REVENUES FOR INVOKANA ($BN),
  • DIABETES DRUGS MARKET, GLOBAL, ANNUAL REVENUE FOR JARDIANCE ($BN),

Invokana significantly reduces the risk of stroke and other cardiovascular events, as well as augmenting weight loss in T##DM.

  • Insulin
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Eli Lilly & Co.
  • Johnson & Johnson
  • 6.1.4 NON-INSULIN INJECTABLE DRUGS
  • 5.1 MARKET DRIVERS

Trulicity can benefit on the composite endpoint appeared to be driven by cardiovascular deaths, with no effect on non-fatal myocardial infarctions or strokes.

  • Insulin
  • Canada
  • North America
  • AgaMatrix, Inc.
  • AstraZeneca PLC

In addition, a large number of patients with myocardial infarction and stroke have diabetes as an underlying disease.

  • Insulin
  • Western Europe
  • Forecast
  • Insulet Corporation
  • Medtronic, Inc.

Controlling high blood sugar helps prevent heart disease, strokes, kidney disease, circulation problems, and blindness.

  • Insulin
  • China
  • Bayer AG
  • Beijing Taiyang Pharmaceutical Group
  • Eli Lilly & Co.
  • CHAPTER III

Among the top ## facilities on stream, ## locate in Jiangsu province, ## Jinlin province, ## in Hubei province, ## in Tianjin city, ## in Zhejiang province, ## in Shanghai city, ## in Liaoning province, ## in Guangdong Province, ## in Beijing city, ## in Sichuan province, ## in Hunan province

  • Insulin
  • China
  • Eli Lilly & Co.
  • Hangzhou Sanofi Aventis Minsheng Pharmaceutical Co., Ltd
  • Zhejiang Expressway Co., Ltd.

Every year ##. ## million people die of cardiovascular disease (about one third of all deaths), ##. ## million people die of heart disease, ##. ## million of stroke, that is, ##. ##% of death is caused by cardiovascular disease.

  • Insulin
  • China
  • Demand
  • Supply
  • Shenzhen Keing Biotech Co., Ltd
  • Chapter V
  • CHAPTER III

According to one study, overweight patients treated with motorman compared with diet alone, had relative risk reductions of ##% for any diabetes endpoint, ##% for diabetes related death and ##% for all cause mortality and stroke.

  • Insulin
  • China
  • Demand
  • Market Size
  • Eli Lilly & Co.

Controlling high blood sugar helps prevent heart disease, strokes, kidney disease, circulation problems, and blindness.

  • Insulin
  • China
  • GSK China Inc.
  • Novo Nordisk Pharmaceutical Co., Ltd.
  • Zhejiang Expressway Co., Ltd.

Note: ##.

  • Insulin
  • Northern Europe
  • Scandinavia
  • Western Europe
  • Forecast
  • Insulin Pumps Outlook

By the year 2040, ## adult in ## will have diabetes.

  • Insulin
  • Insulin Delivery
  • World
  • Market Size
  • Animas Corporation

EVERY YEAR ##. ## MILLION PEOPLE DIE OF CARDIOVASCULAR DISEASE (ABOUT ONE THIRD OF ALL DEATHS), ##. ## MILLION PEOPLE DIE OF HEART DISEASE, ##. ## MILLION OF STROKE, THAT IS, ##. ##% OF DEATH IS CAUSED BY CARDIOVASCULAR DISEASE.

  • Insulin
  • China
  • Demand
  • Market Size
  • Supply

ADC is one such approach.

  • Insulin
  • Biogen Idec Inc.
  • Novo Nordisk Group
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
  • Introduction

Comorbidities of diabetes include heart disease, stroke, kidney disease, and blindness.

  • Insulin
  • Market Size
  • Insulet Corporation
  • Medtronic, Inc.
  • Roche Group

Diabetes is also a cause of co-morbidities such as heart disease, stroke, kidney disease, blindness, and other debilitating diseases.

  • Insulin
  • Eli Lilly & Co.
  • Medtronic, Inc.
  • Novo Nordisk Group
  • Sanofi S.A.

Sweden ##.

  • Insulin
  • Northern Europe
  • Western Europe
  • Forecast
  • Roche Group
  • JUN 04, 2012: DEBIOTECH ANNOUNCES START OF FIRST CLINICAL USE OF JEWEL PUMP ON DIABETIC PATIENTS

The accuracy and precision of the JewelPump™, where every stroke of ##. ## Unit stays well within ##% deviation, makes it a unique opportunity to design more precise closed-loop algorithms. "

  • Insulin
  • Medical Device
  • Therapy
  • World
  • Debiotech S.A.
  • Typical Practices

Diabetes is a chief reason for blindness, kidney failure, cardiac arrest, stroke and lower limb amputation.

  • Insulin
  • World
  • Nipro Corporation
  • Novo Nordisk Group
  • Nuova Aptaca SRL

Also, it is estimated that one-third of all the adults and one-sixth of the children and adolescents in the US are obese.

  • Insulin
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • Sanofi S.A.

MACROVASCULAR COMPLICATIONS - THESE INCLUDE PERIPHERAL VASCULAR DISEASE AND STROKE.

  • Insulin
  • United States
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Takeda Pharmaceutical Company Limited
  • SEMAGLUTIDE: SUSTAIN 5 CLINICAL TRIAL RESULTS
  • 3. INTRODUCTION

THIS CAN EVEN LEAD TO HEART ATTACK AND / OR STROKE.

  • Insulin
  • North America
  • United States
  • Boehringer Ingelheim GmbH
  • Sanofi S.A.

As of 2015, one in ## adults had diabetes and this is expected to increase to one in ## by 2040.

  • Insulin
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

" One of the biggest problems we face with stroke patients is that their gains tend to drop off when they leave the hospital, " said Arun Jayaraman, research scientist at the Shirley Ryan Ability Lab and a wearable technology expert.

  • Cardiovascular Disease
  • Clinical Trial
  • Insulin
  • United States
  • Pfizer Inc.

BUT IT IS ONE OF THE MOST IMPORTANT POINTS!

  • Insulin
  • Biocon Limited
  • Hospira, Inc.
  • Roche Group
  • Sandoz Inc.
  • INSULIN RESISTANCE - PIPELINE BY LIXTE BIOTECHNOLOGY HOLDINGS INC, H1 2019
  • INSULIN RESISTANCE - PIPELINE BY F. HOFFMANN-LA ROCHE LTD, H1 2019

One patient with pancreatic cancer received ## cycles of LB-## (## weeks); one with thymoma, ## cycles; one with testicular and one with carcinoid of the lung, ## cycles; two with ovarian, ## and ## cycles; and one with NSCLC and one with duodenal c

  • Insulin
  • United States
  • World
  • Product Initiative
  • Lixte Biotechnology Holdings, Inc.

Glucox Biotech also develops NOX## inhibitors for the treatment of stroke and heart infarction.

  • Insulin
  • United States
  • MC2 Biotek Group
  • POXEL SA
  • XOMA Corporation

If left untreated, diabetes can cause severe complications including cardiovascular disease, stroke, chronic kidney disease and damaged eye vision.

  • Diabetes
  • Insulin
  • United States
  • World
  • Insulet Corporation